Arsenicum album for Health & Longevity - Quick Reference Sheet

Arsenicum album for Health & Longevity

Created on 07/16/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Arsenicum album is homeopathic white arsenic, diluted until most retail products contain little or none of the original substance. Traditional use targets anxiety, digestive, and respiratory complaints, and it was widely distributed for infection prevention. Evidence of benefit is weak and conflicted; the best-controlled trials found no effect. Main harms come from low-strength or contaminated products. (Full Review)

Protocol

Regimen
4 pills, 1–2× daily
Arsenicum album 30C for 3–7 days (public-health protocol)
Potency
30C
6C, 30C, 200C, 1M in use; 30C used in public-health protocols
Administration
Sublingual
Dissolved under the tongue, away from food, coffee, and strong flavors by 15–30 min
Time to effect
Infection prevention
Not established
No reliable time-to-effect; outcomes indistinguishable from natural infection risk
Acute symptoms
Hours–days
Classical practice claims a response to acute dosing; unproven

Benefits

Contraindications
  • Hepatic impairment (cirrhosis, Child-Pugh Class B–C), for low-potency or unverified products
  • Pregnancy or breastfeeding, for low-potency or unverified products
  • Young children, for low-potency or unverified products
  • Serious or rapidly progressing illness (not in place of medical care)
Key Interactions
  • Arsenic chemotherapy (arsenic trioxide / Trisenox), for low-potency products
  • QT-prolonging drugs (e.g., amiodarone, azithromycin), for low-potency products
  • Other arsenic sources (well water, rice, seafood)
  • Substituting for vaccination or proven treatment

Risk & Side Effects

  • High:
  • Medium: Arsenic toxicity from low-potency, mislabeled, or contaminated preparations; opportunity cost of displacing effective prevention and care
  • Low: Batch-to-batch quality and heavy-metal variability
  • Speculative: Homeopathic aggravation and idiosyncratic reactions

Monitoring

Marker Target Why
Urinary arsenic (total & speciated) < 10 µg/L (spot) Detects arsenic from low-potency products, contamination, or other sources
ALT / AST (liver enzymes) ALT ~10–26 U/L Screens for arsenic-related or other liver injury
Complete blood count (CBC) WBC 3.5–6.0 ×10⁹/L; hemoglobin 13.5–15 g/dL (men), 12.5–14.5 g/dL (women) Chronic arsenic can suppress bone marrow and alter blood counts

Cadence: Baseline, recheck at ~4–6 weeks if use continues, then every 3–6 months while use or exposure risk persists

Qualitative Assessment

  • Self-reported anxiety and restlessness
  • Sleep quality and perceived rest
  • Digestive comfort and appetite
  • Energy levels and general sense of wellbeing
  • Frequency of the symptoms that prompted use